Pfizer’s New RSV Vaccine for Pregnant Women on Fast Track | Vaccines | The Vaccine Reaction

Amongst frantic media coverage of increases in cases of (RSV) among children, Pfizer has announced the development of an experimental bivalent RSV vaccine for pregnant mothers in an attempt to protect newborns from being infected with the virus. The pharmaceutical giant plans to submit the results of their RSV vaccine clinical trials to the U.S. Food and Drug Administration (FDA) for approval by the end of the year. In March 2022, the FDA designated...